艾美捷科技代理Terracebiotech品牌全系列产品

Terracebiotech的专业技术源于加州大学旧金山分校医学中心的肺研究小组，该小组曾助力明确肺表面活性物质的特性，随后研发出其合成形式，用于治疗患有呼吸窘迫综合征的早产儿。凭借在肺细胞生物学领域超过 25 年的实践研究经验，Terracebiotech将其专业技术应用于推动医学研究的进一步创新，以改善人类健康。

Terracebiotech的抗体（在人体肺部中特异性靶向肺泡上皮1型或2型细胞）经验证，可高效、可靠地用于以下应用：免疫组织化学 (IHC)；蛋白质印迹法 (Western Blotting)；通过流式细胞分选技术 (FACS) 进行细胞分离；半定量斑点印迹 (Semi-Quantitative Dot Blots)；磁性细胞分选 (Magnetic Cell Sorting)；冷冻免疫电镜 (TEM Cryo-Immunohistochemistry)。

▍Terracebiotech产品列表

Synaptic Systems为神经科学家和细胞生物学科学家提供研究工具,致力于为神经科学和细胞生物学访方面提供最好的抗体。

Synaptic Systems strives to provide you with the best antibodies in neuroscience and cell biology. Most antibodies are exclusively available from Synaptic Systems and have been developed in-house in close collaboration with renowned experts in the field. Our antibodies are well characterized and known for their excellent quality. We are constantly adding new products and offer attractive licensing conditions.

Synaptic system的主要产品包括：

突触活性区相关抗体

Alzheimer's相关抗体

钙离子结合蛋白相关抗体

细胞粘附分子相关抗体

细胞骨架相关抗体

离子通道相关抗体

神经递质转运体相关抗体

突触后蛋白相关抗体

受体蛋白相关抗体

RNA修饰蛋白相关抗体

SNARE蛋白相关抗体

snRNPs相关抗体

突触粘附蛋白相关抗体

转录因子相关抗体

囊泡相关抗体

其它神经/细胞生物学研究抗体

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技特约代理Avidity Biosciences公司产品。

Avidity Biosciences公司位于美国加州La Jolla，是一家专门从事抗体寡核苷酸结合物（AOC™）技术开发的生物技术公司，此项技术结合了单抗组织选择性和寡核苷酸疗法的精确性，克服了寡核苷酸给药屏障。

Avidity Biosciences is a privately-held biotech company pioneering Antibody Oligonucleotide Conjugates (AOC™). AOCs combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.

Antibody oligonucleotide conjugate (AOC™) technology

Avidity’s antibody oligonucleotide conjugate (AOC™) technology utilizes antibodies to target cells and tissues of interest and facilitate the uptake and internalization of oligonucleotide payloads. By combining the cellular and tissue selectivity of antibodies with the selectivity and efficiency of oligo-based approaches, Avidity has demonstrated modulation of disease-related RNAs in diverse cell types and tissues including muscle, heart, liver, tumors and immune cells.